You are here
- Home
- Therapy Areas
- Cardiovascular
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in Hispanic Patients with Stable Coronary Artery Disease
- Disease
- coronary artery disease
- Drug Name
- AZD6140
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Jan 18, 1971
- Study Name
- D5130L00012
- Study Id
- Brilinta (AZD6140)
- ClinicalTrials.gov ID
- NCT01523366
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
